Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 07, 2021

SELL
$106.71 - $143.18 $1.65 Million - $2.21 Million
-15,453 Closed
0 $0
Q2 2021

Jul 20, 2021

SELL
$80.99 - $107.93 $219,320 - $292,274
-2,708 Reduced 14.91%
15,453 $6.6 Million
Q1 2021

Apr 28, 2021

BUY
$84.79 - $104.74 $30,609 - $37,811
361 Added 2.03%
18,161 $6.53 Million
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $1.39 Million - $1.86 Million
17,800 New
17,800 $6.58 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Vancity Investment Management LTD Portfolio

Follow Vancity Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vancity Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Vancity Investment Management LTD with notifications on news.